Document is current
Any future updates will be listed below
-
Authors
DeFilipp, Zachariah
Maus, Marcela V. https://orcid.org/0000-0002-7578-0393
- License Information
-
More Information
Article History
First Online: 27 March 2023
Competing interests
: Z.D. receives research support from Incyte, Corp., Regimmune, Corp and Taiho Oncology, Inc. and has received consulting fees from Kadmon Corp., Omeros Corp., Incyte, Corp., MorphoSys AG, Inhibrx and PharmaBiome AG. M.V.M. is an inventor on patents related to adoptive cell therapies, held by Massachusetts General Hospital (some licensed to Promab) and University of Pennsylvania (some licensed to Novartis). M.V.M. receives Grant/Research support from: Kite Pharma. M.V.M. has served as a consultant for multiple companies involved in cell therapies. M.V.M. holds Equity in 2SeventyBio, Century Therapeutics, Neximmune, Oncternal and TCR2. M.V.M. is on the Board of Directors of 2Seventy Bio.
